News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

July 24, 2026

Biotech Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds

link

June 30, 2026

Ambi Robotics and Pickle Robot Deliver Integrated Physical AI Solution to Fully Automate Inbound Logistics

link

June 18, 2026

Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials

link

June 10, 2026

Pow.Bio Named 2026 World Economic Forum Technology Pioneer

link

June 4, 2026

Hivemind Capital and UC Berkeley Launch darkmatter lab, a First-of-Its-Kind Program and Cornerstone of Hivemind’s Upcoming Venture Fund

link

May 12, 2026

Knit Health Launches with $11.6M Seed to Build Clinical Intelligence AI for Healthcare

link

May 5, 2026

Prolific Machines Sets monoclonal antibody manufacturing record with light-controlled platform

link

April 29, 2026

Laguna Gains FDA IND Clearance for LGNA-100 Therapy

link

April 14, 2026

nEye.ai Secures $80 Million Series C to Scale Optical Circuit Switching for AI Infrastructure

link

March 27, 2026

Totality Biosciences bets on plants to scale human milk oligosaccharides for a wider audience

link

March 18, 2026

Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy

link

March 12, 2026

First InkSpace Imaging MRI Coil in Europe at Leeds Childrens Hospital

link

February 25, 2026

BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines

link

February 23, 2026

Azalea Therapeutics Co-founder and VP Connor Tsuchida named to SF Business Times 40 Under 40

link

February 17, 2026

Sift Biosciences Announces Oversubscribed $3.7m Pre-seed Financing to Advance Next-generation T-cell Immunotherapy Platform

link

Scribe Therapeutics Achieves Second Success Milestone for In Vivo Program in Collaboration with Eli Lilly and Company

link

February 12, 2026

Philips Debuts InkSpace Imaging’s Snuggle Flexible Pediatric MRI Coil

link

Laguna Bio: Basic research on Listeria bacteria leads to unique cancer therapy

link

January 14, 2026

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

link

January 13, 2026

Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors

link